Gold is rallying. Bitcoin is showing signs of life again. And a major medical development from Moderna is putting biotechnology back in the spotlight.
After three consecutive positive weeks, the S&P 500 finally pulled back roughly 2%. Adam and Blake explain why they’re not overly concerned about the move and turn their attention to some of the bigger forces currently shaping the market.
In this episode:
- Why increased U.S. Treasury buybacks could affect interest rates and the dollar
- What’s behind the recent rallies in gold and Bitcoin
- Why Adam and Blake view Bitcoin differently from traditional precious metals
- How blockchain technology could reshape payments and stock trading
- Why Visa and Mastercard may offer a more traditional way to participate in blockchain’s growth
- The latest breakthrough from Moderna involving personalized mRNA cancer treatment
- Why healthcare and biotech are suddenly attracting attention
- What they’re watching from Nvidia during earnings
- A look at Williams-Sonoma as a potentially less volatile opportunity
- Adam’s latest stock idea: industrial-gas company Linde
Adam and Blake also discuss why blockchain’s underlying technology may ultimately prove more important than any single cryptocurrency, and why established payment companies could benefit as the financial system evolves.
At WealthGuard Advisors, we provide fiduciary financial planning and asset management designed around your individual goals.
